A chemiluminescent microfluidic thrombin generation assay for real-time monitoring in patient plasma
This study provides proof-of-concept that the present microfluidic TGA<sub>lum</sub> is applicable for monitoring therapy of pwHA at a global level and monitoring anticoagulant therapy with DOACs using a portable readout device.
Authors
- Mark van Geffen (ORCID: https://orcid.org/0000-0003-1748-0007)
- Waander L. van Heerde (ORCID: https://orcid.org/0000-0001-7101-8775)
- Lisa van Engelshoven
- Saskia E.M. Schols
- Theodora J. Steeghs
- Henriëtte W. Huijzer
- Nicole M.A. Blijlevens
- Cornelis van ’t Veer
- Claudia J. van de Ridder
- Nerissa M.M. Coolen
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
Publication Details
- Journal
- Journal of Thrombosis and Haemostasis
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jtha.2026.01.021
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00